We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Eurotrol Highlights CueSee Range of Quality Control Materials for Critical Care, Laboratories and POC Sites

By LabMedica International staff writers
Posted on 28 Sep 2021
Print article
Illustration
Illustration

Eurotrol, Inc. (Elizabethtown, KY, USA) highlighted its CueSee range of quality control materials for critical care, laboratories and point-of-care sites at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo which took place at the Georgia World Congress Center in Atlanta, September 26-30.

Eurotrol provides quality control materials with specialized formulations for critical care, laboratories and point-of-care sites in hospitals, clinics, proficiency testing providers, standardization bodies and instrument manufacturers (OEM). The company’s menu includes daily QC, calibration verification materials and standards.

At AACC 2021, Eurotrol demonstrated CueSee Ringe, an innovative, patented packaging concept that has modernized the in vitro diagnostics market. A special glass ampoule is sealed inside the CueSee Ringe device. This ampoule breaks with a simple turning motion without the risk of cutting fingers on glass particles or coming into contact with the liquid. After this activation step, the CueSee Ringe functions identically to a standard syringe. The liquid inside the ampoule is not deteriorated by environmental contamination, which reduces pre-analytical errors. This concept is ideal for solutions typically stored in ampoules for quality control, calibration verification, proficiency testing, competency assessment, method validations, and lot comparisons.

Eurotrol also demonstrated its CueSee VeriSTAT that offers complete quality control, cal/ver & reportable range validation for i-STAT test systems. Each liquid covers blood gasses, electrolytes & hematocrit over optimized ranges. Packaged in the new CueSee Ringe, the liquids will have extended open stability of more than five minutes and revolutionary safe opening and simple dosing. Also on display was CueSee Coag in CueSee Mix with its innovative packaging that separates the lyophilized material from the liquid until activation by a simple twist, resulting in a reliable POC Coag QC. CueSee Mix is an innovative dual-chambered device which separates fractions of QC material. CueSee Mix has many applications due to ease of use, no need for pipetting & reduction of matrix interactions – all in a single container. It is ideal for creating liquid matrixes that mimic human specimens & is suitable for QC, proficiency & competency testing, cal/ver & method validation. The CueSee Mix design led to the development of CueSee Coag a unique POC QC. The lyophilized material is kept separate from the liquid until activation by an easy twisting motion. After equilibration, the QC material is safely tested by use of the integrated dropper. CueSee Coag will be available in clinically significant ranges to ensure accurate patient results.

In addition, Eurotrol presented CueSee CO-OX in ACU-Drop II at the event. CueSee CO-OX is a QC for CO-oximeters with real hemoglobin derivatives. Its ACU-Drop II packaging provides long shelf life & ability to provide relevant ranges of all Hgb forms. The two chambered device separates the Hgb fractions until mixed by simply pushing a button. Sampling is easy with the integrated dropper or by attaching a syringe.

Related Links:
Eurotrol, Inc. 

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Auto Clinical Chemistry Analyzer
cobas c 703
New
TORCH Infections Test
TORCH Panel

Print article
ADLM

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.